Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Treatment for Mild Chronic Hypertension during Pregnancy
Chronic Hypertension and Pregnancy (CHAP) Trial Consortium
Research output
:
Contribution to journal
›
Article
›
peer-review
441
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment for Mild Chronic Hypertension during Pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Confidence Interval
100%
Risk Ratio
100%
Chronic Hypertension
100%
Hypertensive Disorders of Pregnancy
100%
Blood Pressure
50%
Treatment Group
50%
Birth Weight
50%
Active Treatment
50%
Preeclampsia
33%
Maternal Complications
33%
Pregnant Women
33%
Preterm Birth
33%
Gestational Age
33%
Severe Hypertension
33%
Small-for-gestational Age
33%
Risk-adjusted
33%
Neonatal Complications
33%
During Pregnancy
16%
Fetus
16%
Fetal Growth
16%
Pregnancy Outcome
16%
Adverse Pregnancy Outcomes
16%
Indicated Preterm Birth
16%
Multicenter Randomized Trial
16%
Singleton
16%
Fetal Death
16%
Systolic Pressure
16%
Heart Blood
16%
Neonatal Death
16%
Antihypertensive Medication
16%
Placental Abruption
16%
Heart-lung
16%
National Heart
16%
Diastolic Pressure
16%
Safety Outcomes
16%
Preeclampsia with Severe Features
16%
Medicine and Dentistry
Blood Pressure
100%
Pre-Eclampsia
100%
Premature Labor
100%
Birth Weight
100%
Treatment Group
100%
Active Treatment
100%
Small for Gestational Age
66%
Gestational Age
66%
Primary Outcome
66%
Pregnant Woman
66%
Fetus Growth
33%
Systolic Blood Pressure
33%
Newborn Death
33%
Fetus Death
33%
Diastolic Blood Pressure
33%
Antihypertensive Agent
33%
Lung
33%
Pharmacology, Toxicology and Pharmaceutical Science
Premature Labor
100%
Preeclampsia
100%
Treatment Group
100%
Small for Date Infant
66%
Antihypertensive Agent
33%
Fetus Death
33%
Newborn Death
33%
Systolic Hypertension
33%